መነሻ › አኩት ባይፊኖታይፒክ ሊውኬሚያ › Washington

በWashington ለአኩት ባይፊኖታይፒክ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ባይፊኖታይፒክ ሊውኬሚያ የሚደረጉ 15 ጥናቶች በWashington ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በWashington ውስጥ ያሉ ከተሞች

Official study text (English)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Fred Hutchinson Cancer Center, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane

ተሳታዮችን በመፈለግ ላይደረጃ 2

365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04375631

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07094750

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma

ተሳታዮችን በመፈለግ ላይደረጃ 3

365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 2

6 Months – 65 Years · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ

6 Months · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1

እስከ እድሜ 80 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT06928662

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኤፕሪ 2026 · NCT04797767

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Seattle Children's Hospital, Seattle

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።